Literature DB >> 19424796

Frequency and factors associated with small intestinal bacterial overgrowth in patients with cirrhosis of the liver and extra hepatic portal venous obstruction.

C P Lakshmi1, Uday C Ghoshal, Sunil Kumar, Amit Goel, Asha Misra, Samir Mohindra, G Choudhuri.   

Abstract

Spontaneous bacterial peritonitis (SBP), a common complication of cirrhosis of liver, might result from translocation of bacteria from the small bowel. However, there is scanty data on frequency of small intestinal bacterial overgrowth (SIBO) in patients with cirrhosis of the liver. There are no data on SIBO in patients with extra-hepatic portal venous obstruction (EHPVO) in the literature. A total of 174 patients with cirrhosis of the liver, 28 with EHPVO and 51 healthy controls were studied for SIBO using glucose hydrogen breath test (GHBT). Persistent rise in breath hydrogen 12 ppm above basal (at least two readings) was considered diagnostic of SIBO. Of 174 patients (age 47.2 +/- 11.9 years, 80.5% male) with cirrhosis due to various causes, 67 (38.5%) were in Child's class A, 70 (40.2%) class B and 37 (21.7%) class C. Of the 174 patients with cirrhosis, 42 (24.14%) had SIBO as compared to 1 of 51 (1.9%) healthy controls (P < 0.0001). Patients with EHPVO had similar frequency of SIBO compared to healthy controls [2/28 (7.14%) vs 1/51 (1.97%), P = ns]. Frequency of SIBO in Child's A, B and C was comparable [13 (18.6%) vs 16 (23.9%) and 13 (35.1%), respectively; P = ns]. Presence of SIBO were not related to ascites, etiology of cirrhosis, and degree of liver dysfunction. SIBO is common in patients with cirrhosis of the liver. Patients with EHPVO do not have higher frequency of SIBO than healthy subjects. SIBO in cirrhosis is not related to the degree of derangement in liver function or of portal hypertension.

Entities:  

Mesh:

Year:  2009        PMID: 19424796     DOI: 10.1007/s10620-009-0826-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  36 in total

1.  Frequency, microbial spectrum and outcome of spontaneous bacterial peritonitis in north India.

Authors:  A S Puri; J Puri; U C Ghoshal; B C Sharma; V A Saraswat; A Ayyagari; S R Naik
Journal:  Indian J Gastroenterol       Date:  1996-07

2.  Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.

Authors:  Bimaljit S Sandhu; Rajesh Gupta; Jayant Sharma; Jagdeep Singh; Nandagudi S Murthy; Shiv K Sarin
Journal:  J Gastroenterol Hepatol       Date:  2005-04       Impact factor: 4.029

3.  Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease.

Authors:  A M Madrid; F Cumsille; C Defilippi
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

4.  Does long-term inhibition of gastric acid secretion with omeprazole lead to small intestinal bacterial overgrowth?

Authors:  G F Nelis; A H Engelage; G Samson
Journal:  Neth J Med       Date:  1994-09       Impact factor: 1.422

5.  A prospective study of bacterial infections in patients with cirrhosis.

Authors:  W R Caly; E Strauss
Journal:  J Hepatol       Date:  1993-07       Impact factor: 25.083

6.  Incidence of predominant methanogenic flora in irritable bowel syndrome patients and apparently healthy controls from North India.

Authors:  S V Rana; S Sharma; S K Sinha; H Kaur; A Sikander; K Singh
Journal:  Dig Dis Sci       Date:  2008-05-21       Impact factor: 3.199

7.  Small bowel bacterial overgrowth and endotoxemia in cirrhosis.

Authors:  Jinhui Wang; Minhu Chen; Guangyu Sun
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2002-07

8.  Etiology of portal hypertension may influence gastrointestinal transit.

Authors:  R Sadik; H Abrahamsson; E Björnsson; A Gunnarsdottir; P O Stotzer
Journal:  Scand J Gastroenterol       Date:  2003-10       Impact factor: 2.423

9.  Small intestinal transit in the portal hypertensive rat.

Authors:  J A Reilly; E M Quigley; C F Forst; L F Rikkers
Journal:  Gastroenterology       Date:  1991-03       Impact factor: 22.682

10.  Small bowel bacterial overgrowth in patients with alcoholic cirrhosis.

Authors:  F C Morencos; G de las Heras Castaño; L Martín Ramos; M J López Arias; F Ledesma; F Pons Romero
Journal:  Dig Dis Sci       Date:  1995-06       Impact factor: 3.199

View more
  8 in total

1.  Is small intestinal bacterial overgrowth a cause of hyperdynamic circulation in cirrhosis?

Authors:  Roman Maslennikov; Chavdar Pavlov; Vladimir Ivashkin
Journal:  Turk J Gastroenterol       Date:  2019-11       Impact factor: 1.852

2.  Patients with irritable bowel syndrome exhale more hydrogen than healthy subjects in fasting state.

Authors:  Sunil Kumar; Asha Misra; Uday C Ghoshal
Journal:  J Neurogastroenterol Motil       Date:  2010-07-26       Impact factor: 4.924

3.  Low-grade small intestinal bacterial overgrowth is common in patients with non-alcoholic steatohepatitis on quantitative jejunal aspirate culture.

Authors:  Uday C Ghoshal; Chalamalasetty Sreenivasa Baba; Ujjala Ghoshal; George Alexander; Asha Misra; Vivek A Saraswat; Gourdas Choudhuri
Journal:  Indian J Gastroenterol       Date:  2017-10-16

4.  Small intestinal bacterial overgrowth and delayed orocecal transit time in patients with cirrhosis and low-grade hepatic encephalopathy.

Authors:  Manish Kumar Lunia; Barjesh Chander Sharma; Sanjeev Sachdeva
Journal:  Hepatol Int       Date:  2012-03-15       Impact factor: 6.047

5.  Small intestinal bacterial overgrowth in patients with inflammatory bowel disease: A case-control study.

Authors:  Uday C Ghoshal; Ankur Yadav; Bushra Fatima; Anand Prakash Agrahari; Asha Misra
Journal:  Indian J Gastroenterol       Date:  2021-08-14

6.  Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis.

Authors:  Roman Maslennikov; Chavdar Pavlov; Vladimir Ivashkin
Journal:  Hepatol Int       Date:  2018-10-04       Impact factor: 6.047

7.  Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With Ascites.

Authors:  Matthew J Stotts; Amanda Cheung; Muhammad B Hammami; David J Westrich; Eric Anderson; Lauren Counts; Alex S Befeler; Adrian M Di Bisceglie; Charlene Prather
Journal:  Cureus       Date:  2021-06-02

8.  Erythromycin versus neomycin in the treatment of hepatic encephalopathy in cirrhosis: a randomized double-blind study.

Authors:  Fernando Gomes Romeiro; Fabio da Silva Yamashiro; Madileine Francely Américo; Luciana Aparecida Corá; Giovanni Faria Silva; José Ricardo de Arruda Miranda; Carlos Antonio Caramori
Journal:  BMC Gastroenterol       Date:  2013-01-16       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.